Mepolizumab reduces nasal polyp size and obstruction in patients with severe chronic rhinosinusitis, results from a large international study suggest. Researchers found that the anti-IL-5 biologic reduced the need for repeat nasal surgery and cut the use of systemic corticosteroids. Patients treated with mepolizumab – who had severe chronic rhinosinusitis with nasal polyps despite continuous ...
Biologic effective in patients with chronic rhinosinusitis with nasal polyps
28 Apr 2021